DVAX pps in Free Fall 4 trading days ahead of FDA decision?
Back to $3.12 again? Shake-n-bake.
This stock is not for the skittish.
The Short on this stock is such a huge gamble because the gap didn't fill so there's no reasonable exit point immediately following approval. In other words, just way too risky.
The pps is so depressed right now that the calls may be worth the horrible pricing.